Literature DB >> 29767288

Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.

Jianyong Xu1.   

Abstract

Mesenchymal stem cells (MSCs) have been intensively studied and applied in regenerative medicine and tissue engineering. Recently, their immune modulation functions make them as attractive potential approaches for autoimmune disease treatment. Systemic lupus erythematosus (SLE) is one type of chronic autoimmune diseases with multi-organ damaged by the immune system. Although current available treatments are effective for some patients, others are refractory for these therapies. The immuno-modulatory and regenerative characteristics of MSCs make them as one promising candidate for treating SLE. Thus, we would discuss their immune modulation effects, pre-clinical and clinical applications, and the potentials for immune tolerance re-establishment in SLE here.

Entities:  

Keywords:  Autoimmune diseases; MSCs; Mesenchymal stem cells; SLE; Systemic lupus erythematosus

Mesh:

Year:  2018        PMID: 29767288     DOI: 10.1007/5584_2018_212

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.

Authors:  Jianyong Xu; Jieting Chen; Wenlei Li; Wei Lian; Jieyong Huang; Baoyu Lai; Lingyun Li; Zhong Huang
Journal:  J Am Soc Nephrol       Date:  2019-10-11       Impact factor: 10.121

Review 2.  Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.

Authors:  Akram Hoseinzadeh; Zahra Rezaieyazdi; Jalil Tavakol Afshari; Ali Mahmoudi; Sahar Heydari; Reza Moradi; Seyed-Alireza Esmaeili; Mahmoud Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-10-22       Impact factor: 6.692

3.  Editorial: Targeting Heterogeneity of Mesenchymal Stem Cells.

Authors:  Qi Zhang; Yan Xu; Jianyong Xu
Journal:  Front Cell Dev Biol       Date:  2022-04-06

4.  Enhanced renoprotective effect of GDNF-modified adipose-derived mesenchymal stem cells on renal interstitial fibrosis.

Authors:  Shulin Li; Yanping Wang; Zhuojun Wang; Lu Chen; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

5.  TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities.

Authors:  Lingyun Li; Lei Yang; Xian Chen; Xiangjuan Chen; Lianghui Diao; Yong Zeng; Jianyong Xu
Journal:  Stem Cell Res Ther       Date:  2022-09-24       Impact factor: 8.079

Review 6.  The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.

Authors:  Hossein Hozhabri; Francesca Piceci Sparascio; Hamidreza Sohrabi; Leila Mousavifar; René Roy; Daniela Scribano; Alessandro De Luca; Cecilia Ambrosi; Meysam Sarshar
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

7.  Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas lpr mice.

Authors:  Hong Kyung Lee; Hyung Sook Kim; Minji Pyo; Eun Jae Park; Sundong Jang; Hye Won Jun; Tae Yong Lee; Kyung Suk Kim; Sang-Cheol Bae; Youngsoo Kim; Jin Tae Hong; Jaesuk Yun; Sang-Bae Han
Journal:  Theranostics       Date:  2020-08-13       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.